Communications presented in international meetings and workshops
(China, Dubai, France, Italy, Germany, Greece, Belgium, USA, Canada, Singapore,...).

A
s of Jan 2013:

Merched A. Lipogenetic Regulation of Vascular Inflammatory Homeostasis and Atherogenesis. Invited. TM 1st World Immunology Online Conference
March 15 – 17, 2012.

Merched A.
Marie Curie individual actions fellowships. Invited. Destination Europe; Europe Career Opportunities Session. January 20, 2012, Boston,
MA, USA
(REA highlights).

Merched A. Lipogenetic disruption of vascular inflammatory homeostasis and atherogenesis.
Lecture. 16th World Congress on Heart Disease,  July
23-26, 2011,
Vancouver, Canada.

Merched A. Vascular inflammation: light at the end of the tunel.
Invited talk. 3rd International Conference on Drug Discovery and Therapy. February 7-
10th, 2011
Dubai, UAE

Merched A. Novel lipid mediators for the resolution of vascular inflammation. Invited talk. Functional Genomics and Personalized Health Care
Conference. October 01,
2010 Santorini, Greece.

Merched A. Anti-inflammatory and Proresolving Lipid Mediators in Vascular Biology.
Invited talk. Lipid Mediators: A New Era. American Heart
Association Scientific Sessions. November
2010 Chicago, USA.

Merched A. Chairman Session Lipid & Atherosclerosis. BIT's 1st Annual International Congress of Cardiology. December 5-7, 2009  Shanghai, China.

Merched A. Bioactive Lipid Mediators and Resolution of Cardiovascular Inflammation. invited talk. BIT's 1st Annual International Congress of
Cardiology
December 5-7, 2009  Shanghai, China.

Merched A.J., Ko K., Gotlinger K.H., Charles N. Serhan C.N., Chan L. Lecture.  Atherosclerosis is a nonresolving form of vascular inflammation,
governed by specific lipid mediators and macrophage responses. Oral. 6eme Congrès Annuel NSFA -
June 9-11, 2009, Avignon, France.
Merched A, Ko K, Tollefson K, Gotlinger K, Serhan CN, and Lawrence Chan L. Role of lipoxin A4 and inflammatory cytokines in the 12/15-
lipoxygenase mediated modulation of atherosclerosis. Oral. American Heart Association: 77th Scientific Sessions,
November 13-16, 2005 Dallas,
TX, USA
.

Merched A, Tollefson K and Chan L. Dynamic involvement of b2 integrins in the initiation and progression of atherosclerosis in the LDLR knockout
mouse model. Poster. American Heart Association: 77th Scientific Sessions,
November 13-16, 2005 Dallas, TX, USA.

Merched A, Tollefson K, Chan L The dynamic involvement of b2 integrins in the initiation and the progression of atherosclerosis in the LDLR knockout
mouse model. Poster. 2eme Congrès Annuel NSFA -
June 9-11, 2005, Biarritz, France.

Merched A, Tollefson K, Chan L. Absence of p21Waf1/Cip1/Sdi1 Modulates Macrophage Differentiation and Inflammatory Response and Protects
Against Atherosclerosis. Oral. American Heart Association: 76nd Scientific Sessions, November 7-10, 2004, New Orleans, LA, USA.  Merched A and
Chan L. Role of p21 (waf1) in the development of atherosclerotic lesions.  Oral. 1er Congrès Annuel NSFA -
10-12 juin 2004, Biarritz , France.

Ko KWS,  Merched AJ, Chan L. Macrophage-Specific Transgenic Overexpression of 15-Lipoxygenase Attenuates Atherosclerosis in ApoE-Deficient
Mice.  Poster. 5th Annual Conference on Arteriosclerosis Thrombosis and Vascular Biology Meeting
May 6-8, 2004, San Francisco, CA,  USA.

Merched A, Williams L and Chan L. p21 deficiency protects against atherosclerosis in apolipoprotein E knockout mice. Poster.  American Heart
Association: 76th Scientific Sessions,
November 2003, Orlando, FL, USA.

Kazuhiro O, Nomura S, Merched A, Pastore L, Beaudet A, Chan L. In-Vivo LDL Receptor Gene Therapy Is Highly effective in Reversing
Hypercholesterolemia in a Mouse Model of Familial Hypercholesterolemia. Poster. The 5th Annual Meeting of the American Society of Gene Therapy.
June 4-8, 2003 in Washington, DC USA.

Oka K, L. Belalcazar M, Merched A, Pastore L, Beaudet A, Chan L. Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-
Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial
Hypercholesterolemia. Oral. The 5th Annual Meeting of the American Society of Gene Therapy. June 5-9,
2002, Boston, MA USA.

Merched A, Williams L and Chan L. Macrophage-specific p53 expression plays a crucial role in atherosclerosis development. Poster. Department of
Medicine Annual Research Symposium April 4,
2002, BCM Houston, TX, USA.

Nomura N, Oka K, Merched A, Pastore P, Beaudet A, Chan L. Long-Term Reversal of Hypercholesterolemia by a Single Injection of a Helper-
Dependent Adenovirus Expressing LDL Receptor Markedly Inhibits Aortic Atherosclerosis Progression in a Mouse Model of Familial
Hypercholesterolemia. Oral. American Heart Association: 74th Scientific Sessions, November
2001, New Orleans, LO, USA.

Belalcazar M, Merched A, Carr B, Antanova E, Chen K-H, Oka K, Lucio P, Beaudet A, Chan L. Somatic Gene Therapy for Long-Term Stable Correction
of Genetic HDL Deficiency and Atherosclerotic Disease in Mice Using a Novel Nontoxic Adenoviral Human ApoA-I Vector. Oral. American Heart
Association: 73d Scientific Sessions, November
2000, New Orleans, LO, USA.

Pastore L., Oka K., Belalcazar M., Kim I.-H., Merched A., Cela R., Lee B., Beaudet A.L., Chan L.. Helper-dependent adenoviral vectors for gene therapy
of atherosclerosis. Oral. The American Society of Human Genetics Fiftieth Annual Meeting October
2000, Philadelphia PA USA.

Dergunov A.D., E. A. Smirnova, A. Merched, S. Visvikis, G. Siest Binding of triglyceride-rich lipoproteins to the LDL receptor in hypertriglyceridemia: role
of apolipoprotein E. Poster. High Density Lipoproteins And Atherosclerosis IAS Satellite Symposium, July 1-3, 2000, Helsinki, Finland.

Chan L, K Oka, M Belalcazar, I-H Kim, A. Merched, K-H Chen, L Pastore, B Lee, A Beaudet. Novel Approaches to the Treatment of Dyslipidemia by
Liver-directed Gene. Oral. The Third Annual Meeting of the American Society of Gene Therapy, May 31 - June 4,
2000 Denver, Colorado, USA.



More ...

Oka K, Kim I-H, Merched A, Pastore L, Beaudet A, Chan L. Long-Term Expression of VLDL Receptor by a Helper-Dependent Adenoviral Vector
Reduces Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia. Oral. American Heart Association: 72nd Scientific Sessions, 8
Novembre
1999, Atlanta, GA, USA.

Guevara NV, Merched A, Kim HS, Antonova EI, Chan L. New insights into the role of p53 in atherosclerosis. Oral. II Minicolloqium Biologie
Perspective, 22-23 March 1
999, Nancy, France.

Terrisse L, Marcoux-Legault K, Merched A, Sirois J, Poirier J, Siest G, Milne R, Rassart E. Niveaux élevés d'apolipoprotéine D dans le liquide céphalo-
rachidien et dans l'hippocampe de patients atteints de la maladie d'Alzheimer. Génétique Humaine au Québec May 21,
1998, Quebec, Canada.

Merched A, Xia Y, Papadopoulou A, Siest G and Visvikis S. Apolipoprotein AIV codon 360 mutation increases with aging and is not associated with
Alzheimer’s disease. Poster. Human Genomics. The basis of the Medicine of Tomorrow, 15-18 March,
1998, Singapour.

Jeandel C, Blain H, Merched A, Visvikis S, and Siest G. La concentration dans le LCR de l’apolipoprotéine E augmentée avec l’avancée en âge.
IVème Réunion Francophones sur la Maladie d’Alzheimer et les Syndromes Apparentées. Poster. 2-4 octobre
1997, Marseille, France.

Jeandel C, Blain H, Merched A, Visvikis S, and Siest G. Concentration dans le LCR de l’apolipoprotéine E dans le maladie d’Alzheimer. IVème
Réunion Francophones sur la Maladie d’Alzheimer et les Syndromes Apparentées. Oral. 2-4 octobre
1997, Marseille, France.

Merched A, L. Terrisse, P. Bertrand, J. Poirier, S. Visvikis, G. Siest, R. Milne, E. Rassart Les apolipoprotéines D et E dans le système nerveux central
des patients Alzheimeriens. IVème Réunion Francophones sur la Maladie d’Alzheimer et les Syndromes Apparentées. Poster. 2-4 octobre
1997,
Marseille, France.

Merched A, S. Visvikis, J.-M. Serot, L. Terrisse, E. Rassart, G. Siest. Génétique de l’apolipoprotéine E et Association avec la transthyrétine, l’
apolipoproteine D et l’actine dans la maladie d’Alzheimer. IVème Réunion Francophones sur la Maladie d’Alzheimer et les Syndromes Apparentées.
Oral. 2-4 octobre
1997, Marseille, France.

Merched A, Blain U, Visvikis S, Jeandel C and Siest G. Le vieillissement et la maladie d’Alzheimer affectent la concentration de l’apolipoprotéine E
dans le liquide céphalorachidien. Oral. IIIème Réunion de la Société de Biologie du Vieillissement. 20 juin
1997, Paris, France.

Merched A, Visvikis S, Blain U, Jeandel C and Siest G Apolipoprotein E in cerebrospinal fluid increases with aging, Alzheimer’s disease and some
neurodegenerative pathologies. Poster. 68th Meeting of the European Atherosclerosis Society. 8-10 mai
1997, Brugge, Belgium.
Prof. Aksam J. Merched's Scientific Communications
More communications: